N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with changes in antibody recognition of the V1/V2 region of gp120.

Samankaltaisia teoksia

• N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with impaired gp120 shedding and gp41 exposure.
  Tekijä: Fischer, P B, et al.
  Julkaistu: (1996)
• The alpha-glucosidase inhibitor N-butyldeoxynojirimycin inhibits human immunodeficiency virus entry at the level of post-CD4 binding.
  Tekijä: Fischer, P B, et al.
  Julkaistu: (1995)
• Possible role of the V3 domain of gp120 in resistance to an amphotericin B derivative (MS8209) blocking human immunodeficiency virus entry.
  Tekijä: Pleskoff, O, et al.
  Julkaistu: (1996)
• Mutations in human immunodeficiency virus type 1 gp41 affect sensitivity to neutralization by gp120 antibodies.
  Tekijä: Back, N K, et al.
  Julkaistu: (1993)
• Antibody cross-competition analysis of the human immunodeficiency virus type 1 gp120 exterior envelope glycoprotein.
  Tekijä: Moore, J P, et al.
  Julkaistu: (1996)